Skip to main content
Midas Edge

Incannex Healthcare Inc.

For the period ended Dec 31, 2025. Filed Feb 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2025 · Filed Feb 13, 2026

IXHL$2.01-8.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Operations and Comprehensive Loss

For the three months ended December 31,For six months ended December 31,
2025202420252024
Revenue from customers-12-86
Operating expenses:
Research and development(2,280)(1,414)(3,401)(4,310)
General and administrative(4,715)(3,602)(10,388)(7,034)
Total operating expenses(6,995)(5,016)(13,789)(11,344)
Loss from operations(6,995)(5,004)(13,789)(11,258)
Other income, net:
R&D tax incentive4829568711,767
Foreign exchange gains/(losses)(24)(326)(37)(331)
Interest expense-(171)-(171)
Interest income5281057
Change in fair value of convertible rights-(179)-(179)
Change in fair value of warrant liabilities-(103)-(103)
ELOC commitment fee-(1,095)-(1,095)
Share of earnings (loss) of joint venture11-17-
Total other income, net474(890)861(55)
Loss before income tax expense(6,521)(5,894)(12,928)(11,313)
Net loss$(6,521)$(5,894)$(12,928)$(11,313)
Other comprehensive income/(loss):
Currency translation adjustment, net of tax(287)(414)(64)(75)
Total comprehensive loss$(6,808)$(6,308)$(12,992)$(11,388)
Net loss per share: Basic and diluted$(0.02)$(0.33)$(0.04)$(0.65)
Weighted average number of shares outstanding, basic and diluted349,464,31717,624,422329,984,35617,563,200
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.